INFINITY PHARMACEUTICALS, INC. (17) | License Agreements (1)

Recent Contracts

Amendment No. 4 to Amended and Restated Development and License Agreement, dated as of March 4, 2019, by and between the Registrant and Intellikine LLC (Filed With SEC on May 7, 2019)